You'll continue to hear buzz about Avandia (rosiglitazone)

January 2014

You'll continue to hear buzz about Avandia (rosiglitazone).

Availability. Avandia will be back on pharmacy shelves...now that FDA will loosen its restrictions.

FDA says there's not enough evidence that Avandia increases the risk of heart attacks...even though some experts disagree.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Opioids the rampant misuse and abuse of controlled substances (oxycodone, alprazolam, etc)
Allergic Reactions how to handle dye allergies
Insulin Sliding scale insulin is like giving patients a ride on the blood glucose roller coaster
Contraceptives whether levonorgestrel emergency contraceptives (Plan B One-Step, etc) are effective in heavier women
Statins more statin Rxs for lowering heart risk
Interactions how to handle drug interaction alerts for clarithromycin with calcium channel blockers (amlodipine, etc)
Diabetes Meds You'll continue to hear buzz about Avandia (rosiglitazone)
OTC Products Patients will ask questions about "relaxation drinks"
Pediatrics increasing use of SSRIs (fluoxetine, citalopram, sertraline, etc) in children and adolescents
COPD help prevent hospital admissions for chronic obstructive pulmonary disease (COPD)
Pregnancy using ondansetron (Zofran, etc) for morning sickness
Healthy Lifestyles New lifestyle guidelines will help patients with New Year's resolutions to improve their health and lower heart risk